Recursion Pharmaceuticals, Inc. · NASDAQ:RXRX

Dar Zavain received 4,607 Recursion Pharmaceuticals, Inc. shares as an award (Form 4)

Traded Oct 1, 2026 · Filed Oct 2, 2026

On Oct 1, 2026, Dar Zavain (Director) received 4,607 Recursion Pharmaceuticals, Inc. shares as an award, leaving 245,371 shares. Filed Oct 2, 2026 (Form 4).

Awarded
4,607 shares
Holding after
245,371 shares
Trading plan
No
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Oct 1, 2026Class A Common StockAward4,607245,371Direct

Source

View original at SEC

Related